RankingsPricing
  1. US-listed companies
  2. ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc.CLPT

Market cap
$298.89M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Cash and cash equivalents24953936205428
Short-term investments----------10
Accounts receivable, net445,432770,352468,9491865,943949,41511223
Inventory, net899,7021222223359
Prepaid expenses and other current assets63,234174,87029,22097,249134,996192,727213,684357,227012
Total current assets36129613710256251
Property and equipment, net1903,160482,970440,606328,249267,667377,706447,162011
Operating lease rights of use-------374,218322
Software license inventory1927,500910,000937,100976,900871,900801,900504,400110
Licensing rights--------001
Other assets26,900103,783285,498193,38610,64111,64122,538217,573000
Total assets681310714812306655
Accounts payable21997,090697,8072759,445500,929965,783000
Accrued compensation278,124210,359323,644557,784666,060806,445764,9601233
Other accrued liabilities1310,31711450,424480,159390,838328,460012
Operating Lease, Liability, Current-------113,520011
Deferred Revenue, Current112,725106,859102,710116,009223,117256,178350,9631111
Total current liabilities410-83424357
Operating Lease, Liability, Noncurrent-------276,669222
Deferred Revenue, Noncurrent-------197,862000
Secured Long-Term Debt, Noncurrent195,549232,405-------1010
Total liabilities1115-128867271719
Common Stock, Value, Issued484,187585,369748,424913,81436,220106,937110,183152,353000
Additional paid-in capital---8393107109117122182187
Accumulated deficit-65,495,746-72,752,602-77,277,334-85,726,580-93,868,764-101,036,117-107,199,586-112,739,620-120-134-150
Total stockholders’ equity-5,737,101-6,833,969-100,330-1,981,139-756,06962524937
Total liabilities and stockholders’ equity681310714812306655